WC
GRTS

Wexford Capital’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Wexford Capital’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,660
Closed -$25.8K – 296
2023
Q4 		$25.8K Buy
+12,660
New +$23.1K 0.01% 170
2021
Q1 		– Sell
-12,461
Closed -$49K – 367
2020
Q4 		$49K Buy
+12,461
New +$37.7K 0.01% 170

Other funds holding GRTS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Wexford Capital's GRTS Position: Q1 2024 in Review

Wexford Capital sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q1 2024, closing a stake of 12,660 shares — an estimated $25.8K sold.

Wexford Capital first reported a position in GRTS in Q4 2020 and held it in 2 quarters. The position peaked at $49K in Q4 2020. 85 funds tracked by Wall St. Rank hold GRTS as of Q1 2024.

  • Wexford Capital reported no remaining Gritstone bio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Wexford Capital sold 12,660 Gritstone bio, Inc. Common Stock shares in Q1 2024, an estimated $25.8K.
  • Wexford Capital first reported a position in Gritstone bio, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Wexford Capital's Gritstone bio, Inc. Common Stock position peaked at $49K in Q4 2020.
  • 85 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2024.

Based on Wexford Capital's 13F filing for Q1 2024, filed 15 May 2024.